These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 669857)

  • 1. Karyotyping of prostatic carcinoma cell line.
    Nelson-Rees WA; Flandermeyer RR
    Int J Cancer; 1978 Jun; 21(6):796-7. PubMed ID: 669857
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosomal analysis of human prostatic adenocarcinoma cell lines.
    Ohnuki Y; Marnell MM; Babcock MS; Lechner JF; Kaighn ME
    Cancer Res; 1980 Mar; 40(3):524-34. PubMed ID: 7471073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
    Kaighn ME; Narayan KS; Ohnuki Y; Lechner JF; Jones LW
    Invest Urol; 1979 Jul; 17(1):16-23. PubMed ID: 447482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a new prostatic carcinoma cell line (TSU-Pr1).
    Iizumi T; Yazaki T; Kanoh S; Kondo I; Koiso K
    J Urol; 1987 Jun; 137(6):1304-6. PubMed ID: 3586177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
    Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C
    Cytogenet Cell Genet; 1999; 87(3-4):225-32. PubMed ID: 10702678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.
    Winkler S; Reimann-Berg N; Murua Escobar H; Loeschke S; Eberle N; Höinghaus R; Nolte I; Bullerdiek J
    Cancer Genet Cytogenet; 2006 Sep; 169(2):154-8. PubMed ID: 16938574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1).
    Gingrich JR; Tucker JA; Walther PJ; Day JW; Poulton SH; Webb KS
    J Urol; 1991 Sep; 146(3):915-9. PubMed ID: 1875519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation.
    Erdreich-Epstein A; Ganguly AK; Shi XH; Zimonjic DB; Shackleford GM
    Genes Chromosomes Cancer; 2006 Feb; 45(2):169-81. PubMed ID: 16252261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic carcinoma of human origin transplanted in the golden hamster.
    Abdalla AM; Oliver JA
    J Urol; 1971 Oct; 106(4):590-4. PubMed ID: 4107538
    [No Abstract]   [Full Text] [Related]  

  • 10. The LNCaP cell line--a new model for studies on human prostatic carcinoma.
    Horoszewicz JS; Leong SS; Chu TM; Wajsman ZL; Friedman M; Papsidero L; Kim U; Chai LS; Kakati S; Arya SK; Sandberg AA
    Prog Clin Biol Res; 1980; 37():115-32. PubMed ID: 7384082
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification by C-banding of two human prostate tumour cell lines, 1013L and DU 145.
    Hartley-Asp B; Billström A; Kruse E
    Int J Cancer; 1989 Jul; 44(1):161-4. PubMed ID: 2744886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic evidence of intratumoral focal heterogeneity in prostatic carcinomas.
    Wullich B; Breitkreuz T; Zwergel T; Unteregger G; Seitz G; Zang KD
    Urol Int; 1992; 48(4):372-7. PubMed ID: 1413297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of immortalized human cell lines from prostatic carcinoma and benign prostatic hyperplasia.
    Iype PT; Iype LE; Verma M; Kaighn ME
    Int J Oncol; 1998 Feb; 12(2):257-63. PubMed ID: 9458347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new human prostate carcinoma cell line, 22Rv1.
    Sramkoski RM; Pretlow TG; Giaconia JM; Pretlow TP; Schwartz S; Sy MS; Marengo SR; Rhim JS; Zhang D; Jacobberger JW
    In Vitro Cell Dev Biol Anim; 1999; 35(7):403-9. PubMed ID: 10462204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
    Vukovic B; Beheshti B; Park P; Lim G; Bayani J; Zielenska M; Squire JA
    Cytogenet Genome Res; 2007; 116(1-2):1-11. PubMed ID: 17268171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and ploidy analysis of prostatic adenocarcinoma.
    Perlman EJ; Epstein JI; Long PP; Pizov G; Griffin CA
    Mod Pathol; 1993 May; 6(3):348-52. PubMed ID: 8346183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic studies of prostatic cancer.
    Lundgren R
    Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8.
    Ichikawa T; Nihei N; Suzuki H; Oshimura M; Emi M; Nakamura Y; Hayata I; Isaacs JT; Shimazaki J
    Cancer Res; 1994 May; 54(9):2299-302. PubMed ID: 8162568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour ploidy and prognosis in carcinomas of the bladder and prostate.
    Tavares AS; Costa J; de Carvalho A; Reis M
    Br J Cancer; 1966 Sep; 20(3):438-41. PubMed ID: 5950876
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice.
    Ware JL; Paulson DF; Mickey GH; Webb KS
    J Urol; 1982 Nov; 128(5):1064-7. PubMed ID: 7176035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.